Favipiravir: A New Medication for the Ebola Virus Disease Pandemic

Disaster Medicine and Public Health Preparedness

Volumn 9, Issue 1, 2015, Pages 79-81

  Nagata, Takashi ^a   Lefor, Alan K ^b   Hasegawa, Manabu ^c   Ishii, Masami ^d  

^a Japan   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Shimonoseki city Public Health Center   (Japan)

^d World Medical Association   (Japan)

Author keywords

Anti Infective Agents; Disease Outbreaks; Human; Influenza

Indexed keywords

AMIDE; ANTIVIRUS AGENT; FAVIPIRAVIR; PYRAZINE DERIVATIVE;

DISASTER PLANNING; DRUG APPROVAL; HEMORRHAGIC FEVER, EBOLA; HUMAN; JAPAN;

AMIDES; ANTIVIRAL AGENTS; DISASTER PLANNING; DRUG APPROVAL; HEMORRHAGIC FEVER, EBOLA; HUMANS; JAPAN; PYRAZINES;

EID: 84924630804     PISSN: 19357893     EISSN: 1938744X     Source Type: Journal    
DOI: 10.1017/dmp.2014.151     Document Type: Article

References (11)

1. Smither SJ, Eastaugh LS, Steward JA, et al. Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model. Antiviral Res. 2014;104:153-155.
2. Oestereich L, Lüdtke A, Wurr S, et al. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res. 2014;105:17-21.
3. Park S, Kim JI, Lee I, et al. Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A (H1N1) infection in mice. PloS One. 2014;9(7):e101325.
4. Mendenhall M, Russell A, Smee DF, et al. Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever. PLoS Negl Trop Dis. 2011;5(10):e1342.
5. Maganga GD, Kapetshi J, Berthet N, et al. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med. 2014;371(22):2083-2091.
6. World Health Organization. WHO: Ebola Response Roadmap Update 17 October 2014. http://apps.who.int/iris/bitstream/10665/136645/1/roadmapupdate17Oct14-eng.pdf. Accessed November 23, 2014.
7. Pharmaceuticals and Medical Device Agency, Japan. Result of the Examination for Favipiravior [in Japanese]. http://www.info.pmda.go.jp/shinyaku/P201400047/left.html. Accessed October 21, 2014.
8. Ministry of Health, Welfare and Labor, Japan. Summary of media conference by Tamura Ministry of Health, Welfare and Labor, on August 15, 2014 [in Japanese]. http://www.mhlw.go.jp/stf/kaiken/daijin/0000054819.html. Accessed October 21, 2014.
9. Prime Minister of Japan and His Cabinet. Officail Media Conference on the current situation of Ebola Virus Disease by the Chief Cabinet Secretary Yoshihide Suga on August 25 2014 [in Japanese]. http://www.kantei.go.jp/jp/tyoukanpress/201408/25-a.html. Accessed October 21, 2014.
10. Fuji Film News Release. The application of Avigan on the patients infected by Ebola virus disease [in Japanese]. October 6, 2014. http://www.fujifilm.co.jp/corporate/news/articleffnr-0918.html. Accessed October 21, 2014.
11. World Medical Association. WMA Resolution on Unproven Therapy and the Ebola Virus. http://www.wma.net/en/30publications/10policies/e20/index.html. Adopted October 2014. Accessed October 21, 2014.